Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    YFK

No quotes available
-- EUR   0.00%
07/08 3SBIO : gets nod for colorectal cancer drug clinical trial
06/03 3SBIO INC. : (01530) says ITP drug get clinical trial approval
05/20 3SBIO INC. : (01530) withdraws breast cancer drug application
 SummaryQuotesNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( CNY)
Sales 2016 2 834 M
EBIT 2016 929 M
Net income 2016 764 M
Debt 2016 655 M
Yield 2016 -
Sales 2017 3 517 M
EBIT 2017 1 171 M
Net income 2017 1 007 M
Finance 2017 157 M
Yield 2017 0,11%
P/E ratio 2016 25,29
P/E ratio 2017 19,17
EV / Sales2016 6,99x
EV / Sales2017 5,40x
Capitalization 19 143 M
More Financials
Company
3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products.It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.The company... 
Sector
Pharmaceuticals
Calendar
03/21Earnings Release
More about the company
Surperformance© ratings of 3SBio Inc. (ADR)
Trading Rating : Investor Rating :
More Ratings
Latest news on 3SBIO INC. (ADR)
07/08 3SBIO : gets nod for colorectal cancer drug clinical trial
06/03 3SBIO INC. : (01530) says ITP drug get clinical trial approval
05/20 3SBIO INC. : (01530) withdraws breast cancer drug application
03/17 3SBIO : PEG-irinotecan Wins IND Approval From China FDA
03/04 3SBIO : Bought CNY3.9bn Shares in CPGJ
03/04 3SBIO : adds stake in CP Guojian Pharma at Rmb3.9bn
02/23 3SBIO : Wins Financing for Further Equity Investment
02/23 3SBIO : inks Rmb2.2bn term loan facility
01/27 3SBIO : to add stake in CP Guojian Pharmaceutical
01/20 3SBIO : to add stake in CP Guojian
More news
Sector news : Biopharmaceuticals
03:37pDJARROWHEAD PHARMACEUTICALS : Amgen, Arrowhead Pharma Agree to Cardiovascular Coll..
02:40pDJGLAXOSMITHKLINE : Appoints New Consumer Healthcare Chief
10:26aDJNOVO NORDISK A/S : to Cut 1,000 Jobs Amid Growing Competition -- Update
09/28DJINTRA CELLULAR THERAPIES : Shares Plunge After Disappointing Drug Trial Results
09/28DJGLAXOSMITHKLINE : to Sell Remaining 6.2% Stake in Aspen Pharmacare
More sector news : Biopharmaceuticals
Advertisement
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 9,25  CNY
Spread / Average Target 22%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Jing Lou Chairman, President & Chief Executive Officer
Wei hong Xiao Chief Operating Officer
Bo Tan Chief Financial Officer & Executive Director
Dong Mei Su Executive Director
Bin Huang Executive Director & Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
3SBIO INC. (ADR)0.00%2 870
CSL LIMITED2.65%38 089
ALEXION PHARMACEUTICAL..-35.12%27 753
GRIFOLS SA-9.50%13 423
3SBIO INC-18.61%2 870
JIANGXI BOYA BIO-PHARM..--.--%2 536
More Results